AbbVie
ABBV
#29
Rank
HK$3.720 T
Marketcap
HK$2,106
Share price
-1.12%
Change (1 day)
16.21%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): HK$68.00 Billion

According to AbbVie's latest financial reports the company's current earnings are HK$64.38 Billion. In 2025 the company made an earning of HK$51.76 Billion, an increase over its 2024 earnings that were of HK$29.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$68.00 B31.38%
2025 HK$51.76 B77.53%
2024 HK$29.15 B-40.54%
2023 HK$49.04 B-53.62%
2022 HK$105.75 B3.76%
2021 HK$101.92 B282.25%
2020 HK$26.66 B-59.67%
2019 HK$66.11 B62.13%
2018 HK$40.78 B-32.74%
2017 HK$60.63 B-1.99%
2016 HK$61.86 B18.65%
2015 HK$52.14 B180.5%
2014 HK$18.58 B-55.57%
2013 HK$41.84 B-6.86%
2012 HK$44.92 B56.05%
2011 HK$28.78 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$54.19 B-20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$263.62 B 286.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$80.72 B 18.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$7.93 B-88.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$15.35 Billion-122.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$93.45 B 36.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$112.46 B 64.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$61.90 B-9.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$6.42 B-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA